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AbstrACt
Objectives The objective of this exploratory study was to 
see how the Patient-Reported Apnea Questionnaire (PRAQ) 
may impact the daily clinical practice of sleep centres, and 
why it may or may not work as expected. The hypotheses 
were tested that this patient-reported outcome measure 
makes patients more aware of which of their health 
complaints may be related to obstructive sleep apnoea 
(OSA), and that it improves patient-centredness of care 
by shifting the focus of care away from (only) medical 
problems towards the individual burden of disease and 
quality of life.
Design Mixed methods. The quantitative study (surveys, 
patient records) was a before-and-after study.
setting Three sleep centres in The Netherlands 
(secondary care).
Participants 27 patients and 14 healthcare professionals 
were interviewed. 487 patients completed surveys pre-
implementation, and 377 patients completed surveys post-
implementation of the PRAQ. For the health records, 125 
patients were included in the pre-implementation group, 
and 124 other patients in the post-implementation group.
Interventions The PRAQ was used in clinical practice for 
six successive months.
Outcome measures Scores on individual survey items, 
number of patients receiving non-medical treatment, 
adjustment of treatment at first follow-up, compliance with 
treatment.
results Patients were generally positive about the 
usefulness of the PRAQ before and during the consultation, 
as they felt more informed. Healthcare providers did not 
consider the PRAQ very useful, and they reported minor 
impact on their consultations. The surveys and health 
record study did not show an impact of the PRAQ on 
clinical practice.
Conclusions Implementing the PRAQ may be beneficial 
to patients, but this study does not show much impact 
with regard to patient-centredness of care. New Dutch 
guidelines for OSA care may lead to a greater emphasis 
on quality of life and value of care for patients, making its 
integration in clinical care potentially more useful.
IntrODuCtIOn
The integration of patient-reported outcome 
measures (PROMs) in clinical practice has 
been gaining popularity in the past decade.1–3 
PROM data collected in clinical practice can 
be aggregated and used for quality improve-
ment purposes, or individual scores can be 
used in daily clinical practice to improve 
patient care. In this latter function PROMs 
can be used in different ways, for example, 
as a screening tool, a monitoring or evalu-
ation tool, a tool to inform and empower 
patients and/or to increase the patient-cen-
tredness of care by shifting the focus of care 
away from (only) medical problems towards 
the problems patients experience in their 
daily life.4 When using PROMs in daily clin-
ical practice, it may be sensible to combine 
the use of a PROM on an individual patient 
level with application on an aggregate level.5 
There have been a number of studies that 
aimed to evaluate the usefulness of PROMs 
in clinical practice in a variety of settings, of 
which the results are mixed.6–8 Though qual-
itative research on this topic has been synthe-
sised in a recent review4 9 including a list of 
hypotheses on how PROMs might work, there 
strengths and limitations of this study
 ► The mixed methods approach of this exploratory 
study is its major strength: the study provides insight 
into the reasons why the Patient-Reported Apnea 
Questionnaire (PRAQ) does not work as intended.
 ► The patient survey may not have been discrimina-
tive enough to show differences between the groups 
pre-implementation and post-implementation of the 
PRAQ.
 ► Electronic health records were only studied in one 
of the included sleep centres – however taking into 
account the interview results we do not expect dif-
ferent results in the other centres.
 ► The PRAQ was in practice not used for follow-up 
consultations as often as intended, making evalua-
tion of its use in this setting less robust.
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are still many questions regarding which PROMs can be 
potentially useful in which settings.
This study is focused on the application of individual 
PROM scores in sleep centres which diagnose and treat 
patients with obstructive sleep apnoea (OSA), a condi-
tion for which a PROM could be a useful tool to improve 
patient-centredness of care. OSA is a highly prevalent but 
often unrecognised condition in which frequent collapse 
of the upper airway causes breathing stops while asleep. 
The subsequent arousals can result in severe sleepiness 
and fatigue during the day, often affecting a patient’s 
cognitive function, psychological well-being, relation-
ships and ability to work.10–12 OSA has also been shown 
to be an independent risk factor for hypertension, heart 
failure and diabetes.13–15 The prevalence of OSA has been 
reported to be 6% to 38%, depending on the exact defi-
nition of OSA and the population studied, and is higher 
in men.16
Severity of OSA and necessity for treatment has histor-
ically been based on the number of (partial) breathing 
stops per hour: the Apnoea-Hypopnea Index (AHI).17 18 
However, there is no linear association between AHI and 
severity of symptoms or the presence of comorbidities.19–23 
There is also little evidence that treating patients with 
mild OSA (based on AHI) or patients with low sleepiness 
is useful in preventing cardiovascular disease or inci-
dents.24–27 In the past few years there has therefore been 
international discussion regarding new approaches to 
diagnose ‘clinically relevant’ OSA.28 29 This discussion has 
also made its way into recent Dutch guidelines for OSA, in 
which it is recommended that there should be a greater 
focus on the presence of potentially related comorbidi-
ties, as well as the experienced burden of disease for indi-
vidual patients. The goal of treatment is the improvement 
of these aspects of OSA.30
We have developed and validated a PROM for use in 
clinical practice which may aid this new focus of care for 
patients with OSA: the Patient-Reported Apnea Question-
naire (PRAQ),31 32 which measures OSA-related quality of 
life. The goal of this PROM is to improve patient-centred-
ness of care on an individual level by shifting the conver-
sation away from the medical problems and towards and 
individual’s burden of disease/quality of life, and also to 
measure quality of care on an aggregate level. To develop 
the PRAQ, the input from patients and healthcare profes-
sionals was used to select the topics that were considered 
most important to discuss in clinical practice.31 The indi-
vidual PRAQ scores of each patient with (suspected) OSA 
are captured in the ‘PRAQ-report’, which was designed 
together with patients and uses coloured smileys to show 
the results for the 10 domains of the PRAQ. The advan-
tage of the PRAQ compared with other commonly used 
PROMs in the care for patients with OSA (such as the 
Epworth Sleepiness Scale, Functional Outcomes of Sleep 
Questionnaire, etc) is that it provides a comprehensive 
overview of the possibly impacted aspects of quality of 
life that patients with OSA may experience. It is there-
fore potentially suitable for shifting the focus of care away 
from (only) medical problems towards the problems 
patients experience in their daily life.
This explorative study aims to study the impact of the 
PRAQ and PRAQ-report on the clinical practice of OSA, 
and explore why the PRAQ did or did not have an impact. 
A combination of both qualitative and quantitative 
methods is used that will add to the general knowledge 
on the circumstances under which PROMs do or do not 
work in clinical practice.
MethODs
This article describes an exploratory mixed methods 
study in which the PRAQ is implemented in the clinical 
practice of three sleep centres. Qualitative interviews 
and a patient survey were used to explore patients’ and 
healthcare providers’ experiences with the PRAQ, and 
to identify potential barriers and facilitators to its use. 
Additionally, data were collected from electronic health 
records to study whether the hypotheses about the poten-
tial impact of the PRAQ mentioned in the introduc-
tion are correct. For the patient survey and the patient 
record study we conducted a before-and-after study. The 
different methods are described in more detail in the 
next sections.
hypotheses
We have several hypotheses regarding how the PRAQ may 
influence patients and healthcare professionals, and how 
this could impact clinical practice. First of all, completing 
the PRAQ could:
 ► Encourage patients to consider which problems they 
experience that might be related to OSA and that they 
might want to discuss.
 ► Aid healthcare professionals in opening a conversa-
tion about an individual patient’s burden of disease 
(apnoea-related quality of life).
 ► Aid healthcare professionals to evaluate treatment 
and identify problems that are still present.
We think that this may potentially lead to:
 ► Higher patient compliance with treatment.
 ► More explicit choices regarding whether clinical 
treatment for OSA is (potentially) beneficial to the 
patient.
 ► An increase in referrals to other healthcare providers, 
such as psychologists.
 ► More ‘holistic’ care, in which there is increased 
attention for the well-being of patients, including 
the psychological and social effects of OSA and its 
comorbidities.
the PrAQ and its implementation
The PRAQ and its complementary PRAQ-report were 
designed with the input of patients with OSA and health-
care professionals.31 The questions of the PRAQ can 
be found in online supplementary file 1. The PRAQ 
takes approximately 15 min to complete.31 More infor-
mation about the PRAQ-report and how the PRAQ 
 o
n
 22 July 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-025963 on 14 June 2019. Downloaded from 
3Abma IL, et al. BMJ Open 2019;9:e025963. doi:10.1136/bmjopen-2018-025963
Open access
was implemented in clinical practice can be found in 
online supplementary file 2.
setting and subjects
Sleep centres of three Dutch hospitals took part in the 
study. The PRAQ was part of the clinical practice routine 
of these centres for six successive months. The PRAQ was 
distributed to patients attending an intake consultation 
for possible OSA (which takes place after a patient’s diag-
nostic sleep study), and subsequently to the subselection 
of these intake patients diagnosed with OSA who returned 
for a follow-up consultation after starting treatment.
Interviews
In-depth, semi-structured interviews were conducted with 
patients and healthcare professionals in the last 2 months 
of the study. The interview guides contained broad, open 
questions as well as more specific questions informed 
by topics previously identified in the literature.4 For 
patients the main goal was to assess whether completing 
the PRAQ was acceptable to them, and to find out the 
impact that the PRAQ and the PRAQ-report had for them 
on the (preparation for) the consultation. For healthcare 
providers, questions were mostly focused on how they 
used the PRAQ and why they used it this way, and the 
impact the use of the PRAQ has on their practice. This 
information can provide the basis for interpreting the 
results of the electronic health record study.
Patients were invited via email by the sleep centre 
before their scheduled consultation, or by their health-
care professional directly after their consultation (for 
more information see online supplementary file 3). Only 
patients who had completed the PRAQ were invited. We 
interviewed 27 patients. Data saturation was reached. 
Characteristics of the interviewed patients and of the 
interviews can be found in table 1.
All healthcare professionals of the three participating 
sleep centres that had had the option to work with the 
PRAQ were invited to participate. This resulted in inter-
views with 14 healthcare professionals: six pulmonolo-
gists, six physician assistants (PAs) and two nurses. Two 
pulmonologists refused an interview because they had 
not seen many patients for OSA, two others because they 
had not used the PRAQ at all and one PA refused for 
personal reasons. At least four healthcare professionals 
were interviewed at each of the three sleep centres.
More information on the (analysis of) the interviews 
can be found in online supplementary file 3.
surveys
The patient survey was designed for this study to study 
potential differences in patient empowerment and 
patient-centredness of care before and after the imple-
mentation of the PRAQ. The items of the survey covered 
how prepared patients felt for their consultation, whether 
there was discussion of the health problems that patients 
consider relevant during the consultation and whether 
patients were motivated to start their treatment. Patients 
could indicate their agreement on several statements on 
these topics with the statement on a 7-point Likert scale. 
The survey was checked by the members of the research 
team, which included a patient, but was not pilot tested. 
A translated version of the survey can be found in online 
supplementary file 4.
Surveys were distributed by healthcare professionals 
to all of their patients attending either an intake or first 
follow-up consultation for (suspected) OSA. Distribution 
of the surveys took place in the 2 months before imple-
mentation of the intervention (control group), and in 
the last 2 months of the 6 months that the intervention 
was part of daily clinical practice (intervention group). 
For the intervention group, the survey also contained 
additional questions about the patient’s opinion on the 
usefulness of the PRAQ. Participation was voluntary and 
anonymous.
electronic health records
Electronic health records from one of the included 
sleep centres were studied to explore potential changes 
in treatment and compliance with treatment resulting 
from the use of the PRAQ. Data were collected from 
patients with an AHI ≥5 attending an intake consulta-
tion during the final 2 months of the study period and 
during the same time period the previous year. Infor-
mation was collected about treatment choice at intake, 
treatment adaptations and compliance with treatment at 
the first follow-up consultation and patient characteris-
tics. Compliance data is only available for patients who 
receive continuous positive airway pressure (CPAP), the 
most commonly prescribed treatment for patients with 
OSA. As part of standard care, hours of use are registered 
by the CPAP device and entered into the health record 
at follow-up consultations. CPAP compliance is expressed 
as average hours of CPAP use/night in the month before 
the follow-up consultation, with an average of 4 hours/
Table 1 Characteristics of the interviewed patients and the 
interviews
Patient characteristics (n=27)
Age (mean, range) 59 (31–82)
Gender (male) 18
Highest education level (range) Primary school - PhD
Interview characteristics (n=27)
Interview after intake consultation (n) 18
Interview after follow-up consultation (n) 9
Interview together with partner or other 
relative that attended the consultation
4
Patients who had not seen the PRAQ-
report at the time of the interview*
5
*Viewing the PRAQ-report before the consultation was 
optional, and not all healthcare providers showed the report to 
the patient during the consultation. PRAQ, Patient-Reported 
Apnea Questionnaire. 
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night generally being the minimum to be considered 
compliant.33
No identifying information was collected from the 
health records. The data collection procedure guaran-
teed that the records would at all times remain anony-
mous to the researchers.
statistical analyses
Mann-Whitney U tests were conducted for each of the 
survey items that patients were asked to complete both 
pre-implementation and post-implementation of the 
PRAQ. For the electronic health record study, treatment 
choice at intake was studied by aggregating the choice 
into two variables: medical treatment of OSA (eg, CPAP, 
mandibular repositioning device, referral for surgery) 
and no or non-medical treatment (eg, lifestyle advice), as 
these are the variables which we potentially expected the 
PRAQ to influence. A χ2 test was used to test for statistical 
significance. For the follow-up variables of the patient 
record study, χ2 tests (for dichotomous variables) and 
an independent samples t-test (for CPAP compliance in 
minutes) were conducted.
No correction for multiple testing was performed 
because this is an exploratory study. A p value of <0.05 was 
therefore taken as a significant difference, which can be 
interpreted as an indication that this is a potentially inter-
esting variable for a possible future study.
Patient and public involvement
A board member (author MI) of the Dutch patient organ-
isation for OSA (ApneuVereniging) was involved with this 
study from its inception, including the research question 
and outcome measures and interpretation of the results. 
This author was also closely involved in the development 
of the intervention itself (the PRAQ and its complemen-
tary PRAQ-report), as were other members of the patient 
organisation.31 They also approved of the burden and 
time required for the intervention. Patients were not 
involved in the recruitment for the study.
results
Interviews
Patient perspective
Patients were generally willing to complete the PRAQ 
before their consultation, and patient response as 
reported by the healthcare professionals was high. About 
half of the interviewed patients indicated that completing 
the PRAQ helped them prepare for their intake consul-
tation by giving them more insight into their complaints 
and functioning and how this might relate to OSA, and/
or made them consider what they wanted to discuss with 
the healthcare professional. Many patients completed 
the PRAQ with a family member which instigated discus-
sions patients often considered useful. A great majority 
of interviewed patients indicated that they did not mind 
taking the time to complete the PRAQ, and many also 
considered the smileys of the PRAQ-report a clear and 
easy way of communicating the results. Box 1 contains 
quotes illustrating the statements in this paragraph.
The interviews also revealed some unintended effects 
of the PRAQ. A majority of patients assumed that the 
main purpose of the PRAQ was to aid their healthcare 
professional in setting a diagnosis, by providing infor-
mation about symptoms ahead of time. A few patients 
believed that discussion of patient complaints during 
the consultation was therefore no longer necessary after 
completing the PRAQ (box 2), while healthcare profes-
sionals consider this discussion very important (see next 
section). What may have played a role here is that several 
interviewed patients seemed eager to hear their sleep 
study results, rather than (first) spend much time talking 
about their symptoms or problems.
Additionally, there were some issues around the inter-
pretation of the smileys in the PRAQ-report. Several of the 
interviewed patients did not seem to view the PRAQ-re-
port as merely a visualisation of the answers they had 
given, but rather as a ‘test result’. Some considered the 
number of ‘unhappy’ smileys as an indication of whether 
they were doing well or not, which made some patients 
reconsider the severity of their complaints (box 2).
box 1 
‘Look, it’s just very insightful. You can see instantly where the problems 
are and on this other (page) you can see what the improvements are. 
Yes, it’s kinda nice.’ (Centre 3, patient 10)
‘Yes, you know I do find it useful, because you have so many… so 
many things that bother you, that you forget what it is that bothers you. 
Or because it has become part of you, so to say. So yeah in order (not) 
to forget things, a questionnaire like this comes in handy.’ (Centre 2, 
patient 1)
‘But there were quite a lot of questions where I was like, oh, sometimes 
I’m like, how does that fit with (apnoea)? But most did, but there were 
questions where I was like, is that related to sleep apnoea? So. Yes. 
Apparently.’ (Centre 3, patient 7)
‘Actually I liked (seeing it beforehand), because this way I can by my-
self… otherwise I would have gone into it timidly like, tell me, what did 
you see? And now I could ask specific questions.’ (Centre 3, patient 2)
box 2 
‘I think it’s very good, because you can from the beginning very clearly 
indicate your problems. So it doesn’t need to all be done during the 
short conversation you have with the specialist. (…) It’s clear it doesn’t 
need to be mentioned again, because it’s clear to her as well what the 
problems are.’ (Centre 1, patient 4)
‘Just that when you complete a questionnaire aimed at establishing 
something, then it’s useful that you also get a sort of result. So a pre-
liminary… not that you should instantly think like nothing is wrong, 
nothing needs to be done, let’s get out of here. But, I did like it, yeah.’ 
(Centre 1, patient 3)
‘Well, because there were only two orange (smileys), and the others 
were all green and then you think, well…. And then when you look at it 
again then I’m like, ‘I can live with that’.’ (Centre 2, patient 7)
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Healthcare professional perspective
Most healthcare professionals used the PRAQ during 
consultations (table 2), but usually briefly. Several profes-
sionals mentioned that, especially during intake consul-
tations, they used it for the sake of the study. Only a few 
tried to provide more holistic care with the PRAQ. Some 
professionals stated that their minimal use of the PRAQ 
was due to unwillingness to change their practice, while 
others mentioned a general aversion to questionnaires, 
and/or not being convinced that the PRAQ would offer 
new or useful information considering what was already 
discussed during a regular consultation. There were also 
practical issues that to some extent hindered the uptake 
of the PRAQ: most notably the (limited) time avail-
able for consultations, and the fact that the PRAQ was 
not embedded in the electronic health records which 
hindered the regular workflow. There were no notable 
differences in attitude towards the PRAQ between physi-
cians, PAs and nurses.
Most of the professionals that used the PRAQ did 
so at the end of their usual discussion of symptoms, to 
check whether all topics that were problematic had been 
discussed and potentially address more topics. As such 
they could still start the conversation in their usual way, 
allowing patients to explain their problems in their own 
words and allowing the healthcare professionals to ask 
their standard diagnostic questions. Professionals indi-
cated that most ‘symptoms’ that are part of the PRAQ 
were already part of the standard diagnostic questions 
during an intake consultation (sleepiness, problems at 
night), and also overlapped with their usual (diagnostic) 
intake questionnaire. However, several professionals 
mentioned that the PRAQ-report increased discussion of 
the topic ‘health concerns’, which was considered valu-
able. Furthermore, the few professionals that indicated 
that they valued offering more holistic care noticed that 
the PRAQ was useful in drawing the conversation away 
from medical facts and more towards the underlying 
emotions related to a patient’s problems. However, many 
other professionals did not see much added value in 
actively bringing up topics like emotions and social inter-
actions. They were potentially willing to discuss these 
issues but considered it up to the patient to raise them. 
If the PRAQ was used to identify problems, it was more 
common for the professional to mention very briefly that 
these problems were likely to improve with treatment of 
OSA, without further discussing these problems. Profes-
sionals reported that they did not notice any increase in 
OSA-related knowledge in their patients, or a difference 
in whether or how patients raised health complaints or 
quality of life issues of their own accord. Box 3 contains 
quotes illustrating the statements in this paragraph.
With regard to treatment choice, the professionals 
mentioned that the severity of symptoms generally 
only plays a role in patients with an AHI <15, for which 
shared-decision making could potentially lead to a deci-
sion not to start clinical treatment for OSA. If the AHI 
is ≥15, professionals generally wish to treat a patient for 
health reasons irrespective of symptoms. Many patients 
also have a reason to opt for treatment: there is a motor 
vehicle driving ban for untreated patients with AHI ≥15.
Use of the PRAQ during follow-up consultations 
could not be fully evaluated, because a limited number 
of patients had completed the PRAQ at follow-up at the 
time of the interviews. This was due to practical imple-
mentation issues in combination with the relatively short 
duration of the study. However, several healthcare profes-
sionals mentioned that they thought the PRAQ would be 
more useful during follow-up consultations than intake 
conversations, as it would be interesting to see which 
Table 2 Use of PRAQ-report by interviewed healthcare professionals
Use of the PRAQ-report during intake consultations
Discussed it with patients Only looked it up Did not look at it N/A*
8 1 3 2
Use of the PRAQ-report during follow-up consultations
Discussed it with patients Only looked it up Did not look at it Want to use it† N/A*
3 1 3 6 1
*Not all healthcare professionals held both intake and follow-up consultations.
†Did not see (many) patients with follow-up PRAQ but are interested in using it in this setting.
N/A, not applicable; PRAQ, Patient-Reported Apnea Questionnaire. 
box 3 
‘Well I myself don’t ask ‘are you worried about your (health)’? I won’t 
ask that, but that is what it shows. So then… then it’s like ‘hey, I would 
otherwise not have discussed that’.’ (Centre 3, healthcare provider 4)
‘Yes, but then in a solution-oriented way - then you will see someone 
with 30 apnoeas an hour and you see that and you say I hope that (your 
problem with emotions) will get a lot better with the therapy I will start 
for you.’ (Centre 1, healthcare provider 2)
‘Especially I thought people were, uhm… that lack of initiative, not 
going out, right? So they don’t do things because of their sleep prob-
lem, that was what (the Patient-Reported Apnea Questionnaire) often 
showed. And I didn’t always get that from taking the patient history. So 
people maybe find that hard to tell me, or they have trouble indicating 
that it really does have an impact on them. And then they try to focus 
more on the fact than on the underlying emotion. And that would some-
times give added value.’ (Centre 1, healthcare provider 1)
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problems remained after starting treatment (table 2). 
Those that had the opportunity to use the PRAQ in this 
setting mentioned that it was nice to show patients how 
their problems had improved, with the improvement 
sometimes being greater than the patients had realised. 
This could be used as encouragement to continue with 
treatment.
survey results
A total of 487 patients completed surveys pre-implemen-
tation, and 377 patients completed surveys post-imple-
mentation of the PRAQ. Characteristics of the survey 
populations pre-implementation and post-implementa-
tion can be found in table 3.
Patients generally showed high agreement with the 
statements of the survey: 73.3% to 97.3% of patients 
indicated ‘agree’ or ‘completely agree’ per statement 
about the intake and follow-up consultations (table 4). 
Follow-up patients post-implementation showed signifi-
cantly less agreement with the statement ‘In my opinion, 
my treatment is worth it for me’ (p=0.005). The main 
difference between pre-implementation and post-imple-
mentation scores lies in distribution between scores 6 and 
7 (‘agree’ and ‘completely agree’), with 68.2% of pre-im-
plementation patients giving a score of 7, and 54.3% of 
post-implementation patients giving a score of 7. The 
other statements showed no obvious or statistically signifi-
cant differences in the level of agreement pre-implemen-
tation and post-implementation.
Patients showed high agreement with the two state-
ments about the usefulness of the PRAQ-report, partic-
ularly regarding its use during a consultation (table 4). 
However, not all patients had completed the PRAQ and 
seen the PRAQ-report before or during their consul-
tation. Patients who did not look up the PRAQ-report 
before their consultation may also have been the ones 
less interested in using the PRAQ-report, so the reported 
results may be somewhat biased towards are more positive 
evaluation (table 5).
electronic health record results
One hundred and twenty-five patients were included in 
the pre-implementation group, and 124 other patients in 
the post-implementation group. Patient characteristics 
are described in table 6. No differences were found with 
regard to how many patients with OSA received non-med-
ical treatment (either no treatment at all or referral to a 
psychologist (table 7)), or in the number of patients for 
whom treatment was adjusted at the first follow-up consul-
tation after starting CPAP treatment (table 8).
In both groups, 98 patients were prescribed CPAP. 
Patient characteristics did not differ between the two 
groups of patients with CPAP (data not shown). Compli-
ance with CPAP treatment did not differ between the two 
groups (table 8).
DIsCussIOn
This exploratory study showed limited success regarding 
the uptake of the PRAQ in the daily clinical practice of 
sleep centres, and the improvement of patient-centred-
ness of care. From the interviews it became clear that 
most patients were willing to complete the PRAQ and 
were generally positive about the usefulness of the PRAQ 
before the consultation (eg, because of feeling more 
informed) and during the consultation (due to the clear 
visual representation of their problems). This may there-
fore have lead to some improvement of preparation for 
the consultation by patients, and better communication, 
though this is not reflected in the results of the patient 
survey. Among healthcare professionals the willingness 
to use the PRAQ-report in consultations differed, as the 
perceived need was minimal. Most of the professionals 
that used the PRAQ also reported that the impact on their 
consultations was minor. Therefore, it is not surprising 
that comparison of health records pre-implementation 
Table 3 Characteristics of the survey population
Pre-
implementation 
(n=239)
Post-
implementation 
(n=197)
Intake consultations
Age (yrs) 53.9 55.4
Gender (% male) 68.4 69.5
Severity of symptoms* 6.50 6.44
Diagnosed with OSA (%) 82.8 83.2
CPAP† (%) 71.0 70.7
MRA‡ (%) 13.7 19.5
Other treatment† (%) 10.7 7.4
No treatment† (%) 1.0 2.4
Missing† (%) 3.6 0.0
Pre-
implementation 
(n=248)
Post-
implementation 
(n=180)
Follow-up consultations
Age (yrs) 57.33 58.54
Gender (% male) 75.3 69.7
Severity of remaining 
symptoms or problems with 
treatment*
4.25 5.03
CPAP (%) 89.1 89.4
MRA‡ (%) 3.6 3.9
Other§ or missing (%) 7 5.6
*Scale 1–10, higher is more problems.
†Percentage of patients with this treatment of the total of patients 
diagnosed with OSA.
‡Device worn over the teeth that pushes tongue and jaw forward 
to hold the airway open.
§Other possible treatments are surgery of the jaw or throat, 
and methods that will help a patient with positional OSA (who 
experiences breathing stops mainly when they lie on their backs) 
sleep on their side.
CPAP, continuous positive airway pressure; MRA, 
mandibular repositioning device; OSA, obstructive sleep apnoea; 
yrs, years. 
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and post-implementation of the PRAQ did not show any 
differences in treatment choice and CPAP compliance.
The interviews showed that the professionals mostly felt 
that they already sufficiently address the ‘symptom-like’ 
topics of the PRAQ (sleepiness, problems at night) in 
their usual care, in the context of setting a diagnosis. 
The topics of the PRAQ that are not necessary for setting 
a diagnosis, but could potentially be used to motivate 
patients for their treatment, were not seen as essential 
to discuss by many professionals. The limited perceived 
benefit of the PRAQ is likely also mitigated by the fact 
that many steps of the care process have to be covered 
during the intake consultation, including discussing the 
sleep study results and choosing a treatment. This leaves 
little extra time to discuss a patient’s quality of life and 
detailed treatment goals. Furthermore, burden of disease 
plays a limited role in setting a diagnosis when AHI ≥15, 
due to views on strict medical necessity of treatment, 
but also due to the driving ban for untreated patients. 
Therefore, adding the PRAQ to the current practice for 
OSA does not appear to be a sufficient trigger to increase 
attention to quality of life issues.
Patients generally held a more positive view towards the 
usefulness of the PRAQ. From the interviews it became 
clear that completing the PRAQ has the potential to 
give patients more insight into their OSA-related health 
complaints and encourages communication between 
family members. Furthermore, the patient survey results 
indicated that patients thought the PRAQ-report was 
useful for their preparation for the consultation and 
(when it was used by the healthcare professional) during 
the consultation.
Agreement to the patient survey statement ‘I feel like 
my treatment is worth it for me’ was significantly lower 
on the post-implementation survey than on the pre-im-
plementation survey. The main difference was in the 
number of patients indicating ‘agree’ versus ‘completely 
agree’, meaning both pre-implementation and post-im-
plementation of the PRAQ patients were very positive 
about their treatment. This being an exploratory study, 
statistically significant results should be interpreted with 
caution, and we deem the relevance of this finding to be 
limited.
There appears to be room for improvement of commu-
nication around the PRAQ, as there was confusion for 
some patients around the necessity of still discussing symp-
toms during the consultation. Whereas some patients 
seemed to be more interested in hearing their sleep study 
results than talk about their symptoms, for the health-
care professionals hearing about the patient’s symptoms 
in their own words is an essential part of the diagnosis. 
It may be beneficial to communicate the purpose of the 
PRAQ more clearly in the invitation email, and/or to 
instruct professionals to, at the beginning of their consul-
tation, mention the PRAQ to patients and how its results 
will be addressed. More in-depth discussion with the field 
about what is most suitable or desirable in this context is 
needed.
In the past few years, several similar initiatives involving 
PROMs have been introduced in The Netherlands, such 
as the Assessment of Burden of COPD (ABC) tool,34 the 
Nijmegen Clinical Screening Instrument for COPD,35 the 
QLIC-ON PROfile for children36 and myIBDcoach for 
patients with inflammatory bowel disease.37 Studies into 
these applications show promising results regarding their 
benefits37 38 despite some resistance from professionals 
who do not believe in the added benefit or believe the 
tool would be more useful for different professionals 
within the care pathway.39 40 However, the healthcare 
professionals’ scepticism about the potential benefits 
of the PRAQ seems to be more extensive. Potentially, 
professionals will see greater benefit of the PRAQ in the 
context of the recently released new guidelines for OSA30 
with their greater emphasis on (improving) burden of 
disease, which were not yet available at the time of this 
study. However, the question remains whether a more 
‘holistic’ approach to caring for OSA patients fits within 
the current setting of relatively short intake consultations 
which take place after the patients’ diagnostic sleep study. 
It may be necessary to move towards a reorganisation of 
care: for example to plan the intake consultations before 
the sleep study to allow for more focus on the individual 
Table 5 Percentage of patients that completed and viewed 
the PRAQ, and patient opinion on usefulness of the PRAQ
Intake (n=197) Follow-up (n=180)
Completed PRAQ 
before consultation
77.7% 51.1%
Seen PRAQ-report 
before consultation*
40.0% 44.4%
Seen PRAQ-report 
during consultation*
74.1% 60.2%
*This percentage is a sub-percentage of the patients who indicated 
they completed the PRAQ.
PRAQ, Patient-Reported Apnea Questionnaire. 
Table 6 Patient file study: patient characteristics
Pre-
implementation 
(n=125)
Post-
implementation 
(n=124)
Age (SD) 55.4 (12.0) 56.6 (15.7)
Gender 68% male 67.7% male
BMI (SD) 31.4 (6.5) 30.8 (6.1)
AHI (SD) 23.1 (16.1) 25.0 (18.5)
AHI <15 40.8% 33.9%
ESS (SD) 8.0 (4.8) 7.4 (5.0)
Start with CPAP at 
intake
78.4% 79.0%
AHI, Apnoea-Hypopnea Index; BMI, body mass index; CPAP, 
continuous positive airway pressure; ESS, Epworth Sleepiness 
Scale. 
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patients’ symptoms and problems, and to specifically eval-
uate the necessity of doing a diagnostic sleep study. Addi-
tionally, integrating the PRAQ in the electronic health 
record will help professionals fit the PRAQ-report better 
into their workflow.
Another option that can be explored is to adapt the 
PRAQ itself or the context in which it is used, in order 
to fit better to healthcare professionals’ preferences. For 
example, an option would be to remove the domains of 
the PRAQ focused on symptoms that are (nearly) always 
discussed already, and instead put the focus on the addi-
tional domains. It is also possible to distribute the PRAQ 
to a more select group of patients, for example by moving 
the first measurement moment to the follow-up consul-
tation, therefore targeting only patients with a diagnosis 
and treatment. It could then be used to identify those 
patients still experiencing problems. Downside to both of 
these adaptations is that they limit the option to monitor 
changes over time on all domains that are relevant for 
patients with OSA, while monitoring over time is what 
most interviewed healthcare professionals are interested 
in. Not having a baseline measurement would also limit 
the options to usefully study the PRAQ data on aggregate 
level. It may be most feasible to let sleep centres decide 
how they want to use the PRAQ in the context of what is 
desirable to them, which may also evolve over time. It is 
hoped that they will also take into account the patient 
perspective when deciding how to use the PRAQ.
strengths and limitations of the study
The major strength of this study is that we used mixed 
methods, which provides insight into the reasons why the 
PRAQ does not work as intended. Many other studies on 
PROMs study only whether a PROM works, rather than why 
or how.
There are also limitations to the study. First, the survey 
used for this study was not tested and maybe not discrim-
inative enough to show differences between the groups 
pre-implementation and post-implementation of the 
PRAQ. Potentially, patients who have not completed the 
PRAQ do not know that, for example, their preparation for 
the consultation could have been better than it currently 
was. Second, electronic health records were only studied 
in one of the included sleep centres. However, consid-
ering the information we collected in the interviews, we 
do not expect that we would have found different results 
in either of the other two sleep centres. Third, though 
technically there was enough time in this study for profes-
sionals to also use the PRAQ during the first follow-up 
consultation, practical implementation issues as well as a 
lack of initiative from healthcare professionals to actively 
check whether a follow-up PRAQ was available meant that 
Table 7 Treatment choice at intake*
Pre-implementation 
(n=125)
Post-implementation 
(n=124)*
Pre-
implementation, 
AHI <15 (n=51)
Post-
implementation, 
AHI <15 (n=42)
Medical treatment for OSA (incl CPAP) 
(n,%)
123 (98.4) 123 (99.2) 49 (96.1) 41 (97.6)
No medical treatment for OSA (n,%) 2 (1.6) 1 (0.8) 2 (3.9) 1 (2.4)
Referred to psychologist (n, %) 2 (1.6) 0 (0) 2 (3.9) 0 (0)
No treatment (n, %) 0 (0) 1 (0.8) 0 (0) 1 (2.4)
*If nothing is indicated, no significant difference was found.
AHI, Apnoea-Hypopnea Index; CPAP, continuous positive airway pressure; incl, including; OSA, obstructive sleep apnoea. 
Table 8 Treatment adjustments and compliance in patients with CPAP at the first follow-up*
Pre-implementation of PRAQ (n=98) Post-implementation of PRAQ (n=98) Missings
Adjustment of current treatment 45 36 N/A†
Switch to different treatment 5 9 N/A†
Referral to different specialisation 6 2 N/A†
CPAP compliance‡ (SD) 5:47 hours (2:11) 5:53 hours (2:10) Pre-impl.: 11
Post-impl: 7
CPAP compliance<4 hours 25.0% 27.5% Pre-impl.: 11
Post-impl: 7
Stopped CPAP treatment 4.1% 5.1% N/A†
*If nothing is indicated, no significant difference was found.
†If nothing was noted down in the patient health record, it was assumed this did not take place. Therefore missings are not applicable.
‡Hours of CPAP use by patients who had stopped treatment altogether (see ‘stopped CPAP treatment’) are not included in this number.
CPAP, continuous positive airway pressure; impl., implementation; N/A, not applicable; PRAQ, Patient-Reported Apnea Questionnaire. 
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it was not used often at this time point. Therefore we did 
not gain much insight into the potential use of the PRAQ 
for follow-up consultations. Lastly, only patients who 
looked up the PRAQ-report could give an opinion on its 
usefulness for preparing the consultation in the survey. 
However, patients who did not look up the PRAQ-report 
may also be generally less interested in these kinds of tools 
and, if they had looked it up, may have experienced it as 
less useful. Additionally, patients who have a more posi-
tive opinion on the PRAQ may be more likely to complete 
the items on its usefulness.
COnClusIOns
Using the PRAQ in the daily clinical practice of OSA is 
viewed as useful by patients, but the enthusiasm of health-
care professionals differed per individual and was gener-
ally not very great. Implementation of the PRAQ does 
not seem a sufficient trigger to focus more attention to 
quality of life during consultations, and in current prac-
tice does not show impact on treatment choice or CPAP 
compliance. However, new Dutch guidelines for OSA 
care that have recently been published may lead to a 
greater emphasis on quality of life for patients, making 
the integration of the PRAQ in clinical care potentially 
more useful.
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